Effects of pentoxifylline on peritoneal fibroblasts and silica-induced peritoneal fibrosis

Peritoneal Dialysis International

Volumn 23, Issue 3, 2003, Pages 228-236

  Fang, Cheng Chung ^a   Lai, Ming Nan ^b   Chien, Chiang Ting ^a   Hung, Kuan Yu ^c   Tsai, Chien Chen ^c   Tsai, Tun Jun ^a   Hsieh, Bor Shen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Pentoxifylline; Peritoneal fibroblast; Peritoneal fibrosis; Silica

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE 3; CYCLIC AMP; INTERSTITIAL COLLAGENASE; MESSENGER RNA; NEUTROPHIL COLLAGENASE; PENTOXIFYLLINE; PROLINE; SILICON DIOXIDE; TETRAZOLIUM; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL GROWTH; COLLAGEN SYNTHESIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; FIBROBLAST; FIBROSIS; GROWTH STIMULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOASSAY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NORTHERN BLOTTING; OMENTUM; PERITONEAL DISEASE; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0042386771     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302300303     Document Type: Article

References (35)

1. Marshall AJ, Baddeley H, Barritt BW, Davies JD, Lee RE, Low-Beer TS, et al. Practolol peritonitis: a study of 16 cases and a survey of small bowel function in patients taking beta-adrenergic blockers. Quart J Med 1977; 46:135-49.
2. Rottembourg J, Gahl GM, Poignet JL, Mertani E, Strippoli P, Langlois P, et al. Severe abdominal complications in patients undergoing continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 1983; 20:236-42.
3. Slingeneyer A. Preliminary report on a cooperative international study on sclerosing peritonitis. Contrib Nephrol 1987; 57:239-47.
4. Shaldon S, Koch KM, Quellhorst E, Dinarello CA. Pathogenesis of sclerosing peritonitis in CAPD. Trans Am Soc Artif Intern Organs 1984; 30:193-4.
5. Charney DI, Gouge SF. Chemical peritonitis secondary to intraperitoneal vancomycin. Am J Kidney Dis 1991; 17:76-9.
6. Lo WK, Chan KT, Leung ACT, Pang SW, Tse CY. Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11:166-72.
7. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S43-55.
8. Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow VR, Iwatsuki S, et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980; 140:1201-3.
9. Verger C, Brunschvicg O, Charpentier YL, Lavergne A, Vantelon J. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 1981; 18:199-205.
10. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drug 1987; 34:50-97.
11. Berman B, Duncan MR. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol 1989; 92:605-10.
12. Berman B, Duncan MR. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol 1990; 123:339-46.
13. Lai H-S, Chu S-Y, Chen Y, Wu C-H, Lin L-T. Effect of pentoxifylline on intraperitoneal adhesions after intestinal resection in rats. J Formos Med Assoc 1994; 93:911-15.
14. Lee HG, Choi I, Pyun KH, Park KW. Peritoneal lavage fluids stimulate NIH3T3 fibroblast proliferation and contain increased tumour necrosis factor and IL-6 in experimental silica-induced rat peritonitis. Clin Exp Immunol 1995; 100:139-44.
15. Beavis MJ, Williams JD, Hoppe J, Topley N. Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 1997; 51:205-15.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
17. Wroblewski F, La Du JS. Lactate dehydrogenase activity in blood. Proc Soc Exp Biol Med 1955; 90:210-14.
18. Fang CC, Yen CJ, Chen YM, Ko FN, Tsai TJ, Lee PH, et al. Hydralazine inhibits human peritoneal mesothelial cell proliferation and collagen synthesis. Nephrol Dial Transplant 1996; 11:2276-81.
19. Verheijen JH, Nieuwenbroek NME, Beekman B, Hanemaaijer R, Verspaget HW, Ronday HK, et al. Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase. Biochem J 1997; 323:603-9.
20. Pollock CA, Ibels LS, Eckstein RP, Graham JC, Caterson RJ, Mahony JF, et al. Peritoneal morphology on maintenance dialysis. Am J Nephrol 1989; 9:198-204.
21. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11:498-506.
22. Krediet RT, Ho-dac-Pannekeet MM, Struijk DG. Preservation of peritoneal membrane function. Kidney Int Suppl 1996; 56:S62-8.
23. Topley N, Jörres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, et al. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int 1993; 43:226-33.
24. Topley N. The cytokine network controlling peritoneal inflammation. Perit Dial Int 1995; 15(7 Suppl):S35-40.
25. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
26. Mauch C, Kreig T. Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis. Rheum Dis Clin North Am 1990; 16:93-107.
27. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol 1994; 1:229-46.
28. Elias JA, Gustilo K, Baeder W, Freundlich B. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol 1987; 138:3812-16.
29. Dias A, Munoz E, Johnston R, Korn JH, Jimenez SA. Regulation of human lung fibroblast alpha 1(I) pro-collagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. J Biol Chem 1993; 268:10364-71.
30. Jörres A, Ludat K, Lang J, Sander K, Gahl GM, Frei U, et al. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol 1996; 7:2192-201.
31. Desmouliere A, Xu G, Costa AM, Yousef IM, Gabbiani G, Tuchweber B. Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells. J Hepatol 1999; 30:621-31.
32. Strutz F, Heeg M, Kochsiek T, Siemers G, Zeisberg M, Muller GA. Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts. Nephrol Dial Transplant 2000; 15:1535-46.
33. Fang CC, Yen CJ, Chen YM, Shyu RS, Tsai TJ, Lee PH, et al. Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: effects on TGF-β. Kidney Int 2000; 57:2626-33.
34. Clark JG, Kostal KM, Marino BA. Modulation of collagen production following bleomycin-induced pulmonary fibrosis in hamsters. Presence of a factor in lung that increases fibroblast prostaglandin E2 and cAMP and suppresses fibroblast proliferation and collagen production. J Biol Chem 1982; 257:8089-105.
35. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, et al. Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP. FASEB J 1999; 13:1774-86.